LOW PHILIP S (Chief Science Officer) sold 1.8% of their position (5.93K shares) of ENDOCYTE INC on the open market
Open‑market sale worth $92.2K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 10/9/2018ACC: 0001179110-18-012085
DirectorOfficer· Chief Science Officer
Since Oct 2018
-6.22K
Net shares
Net seller
$92.2K
Total sold
1
Open market trades
0B · 1S
2
Total transactions
6.22K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
−294.00
Price / share
—
Trade value
—
% of position
0.1%
9/7/2018
326.04K→325.75K
Common Stock
Direct
Shares
−5.93K
Price / share
$15.56
Trade value
$92.24K
% of position
1.8%
10/5/2018
325.75K→319.82K
Total
Net shares
−6.22K
Net value
-$92.24K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 9/7/2018 | G · Gift | −294.00 | — | — | 0.1% | 326.04K | 325.75K |
| Common Stock Direct | 10/5/2018 | S · Sale | −5.93K | $15.56 | $92.24K | 1.8% | 325.75K | 319.82K |
| Total | −6.22K | -$92.24K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned184.99K
Total
184.99K indirect184.99K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 184.99K | Indirect |
| Total | 184.99K | 184.99K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported